Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond

Autoimmunity Reviews

Volumn 15, Issue 8, 2016, Pages 801-808

  Lucchese, Guglielmo ^a   Kanduc, Darja ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Aicardi Goutieres syndromes; Autoimmunity; Brain calcification; Centriolar and centrosomal proteins; Crossreactivity; Guillain Barr like syndromes; Microcephaly; Ocular anomalies; Peptide sharing; Zika virus infection

Indexed keywords

ABC TRANSPORTER; ACETYL COENZYME A; ADENYLATE CYCLASE; ALPHA N ACETYLGLUCOSAMINIDASE; ASPARTOACYLASE; CYCLIN DEPENDENT KINASE 5; DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED RNA SPECIFIC ADENOSINE DEAMINASE; GAMMA TUBULIN; HEXAPEPTIDE; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; LONG CHAIN FATTY ACID COENZYME A LIGASE; MYELIN; PENTAPEPTIDE; PHOSPHOGLYCERATE DEHYDROGENASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; POLYGLUTAMINE BINDING PROTEIN 1; POLYPROTEIN; PROTEOLIPID PROTEIN; RIBONUCLEASE; RIBONUCLEASE H2 SUBUNIT B; RIBONUCLEASE H2 SUBUNIT C; SODIUM PHOSPHATE COTRANSPORTER 2; SOMATOMEDIN B RECEPTOR; THREE PRIME REPAIR EXONUCLEASE 1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX11; TRANSCRIPTION FACTOR TF3B; TUBULIN GAMMA 1 CHAIN; UNCLASSIFIED DRUG; VACUOLAR PROTEIN SORTING ASSOCIATED PROTEIN 53; NERVE PROTEIN; VIRAL PROTEIN;

AUTOIMMUNITY; BRAIN CALCIFICATION; DEMYELINATION; DISEASE ASSOCIATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE RESPONSE; MICROCEPHALY; NEUROPATHOLOGY; NEUROPATHY; REVIEW; ZIKA FEVER; ZIKA VIRUS; BRAIN; CHEMISTRY; CROSS REACTION; FEMALE; FETUS DISEASE; METABOLISM; PATHOLOGY; PEPTIDE MAPPING; PHYSIOLOGY; PREGNANCY; VIROLOGY;

AUTOIMMUNITY; BRAIN; CROSS REACTIONS; FEMALE; FETAL DISEASES; GUILLAIN-BARRE SYNDROME; HUMANS; MICROCEPHALY; NERVE TISSUE PROTEINS; PEPTIDE MAPPING; POLYPROTEINS; PREGNANCY; VIRAL PROTEINS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84963611430     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.03.020     Document Type: Review

References (64)

1. [1] MacFadden, D.R., Bogoch, I.I., Zika virus infection. CMAJ, Feb 8 2016.
2. [2] Rubin, E.J., Greene, M.F., Baden, L.R., Zika virus and microcephaly. N Engl J Med, 10, Feb 2016.
3. [3] Mlakar, J., Korva, M., Tul, N., Popović, M., Poljšak-Prijatelj, M., Mraz, J., et al. Zika virus associated with microcephaly. N Engl J Med, 10, Feb 2016.
4. [4] Schuler-Faccini, L., Ribeiro, E.M., Feitosa, I.M., Horovitz, D.D., Cavalcanti, D.P., Pessoa, A., et al. Possible association between Zika virus infection and microcephaly—Brazil. MMWR Morb Mortal Wkly Rep. 2016, 65, 2015, 59–62.
5. [5] Peters, B., Sidney, J., Bourne, P., Bui, H.H., Buus, S., Doh, G., et al. The Immune Epitope DataBase and analysis resource: from vision to blueprint. PLoS Biol, 3, 2005, e91.
6. [6] Lucchese, G., Capone, G., Kanduc, D., Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins. Schizophr Bull 40 (2014), 362–375.
7. [7] Lucchese, G., Spinosa, J.P., Kanduc, D., The peptide network between tetanus toxin and human proteins associated with epilepsy. Epilepsy Res Treat, 2014, 2014, 236309.
8. [8] Lucchese, G., Kanduc, D., Potential crossreactivity of human immune responses against HCMV glycoprotein B. Curr Drug Discov Technol, Jan 28 2016.
9. [9] Frank, A., Immunology and Evolution of Infectious Disease. 2002, Princeton University Press, Princeton (NJ).
10. [10] Kanduc, D., Pentapeptides as minimal functional units in cell biology and immunology. Curr Protein Pept Sci 14 (2013), 111–120.
11. [11] Kuno, G., Chang, G.J., Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol 152 (2007), 687–696.
12. [12] UniProt Consortium, The universal protein resource (UniProt) 2009. Nucleic Acids Res 37 (2009), D169–D174.
13. [13] Korenberg, J.R., Chen, X.-N., Schipper, R., Sun, Z., Gonsky, R., Gerwehr, S., et al. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci 91 (1994), 4997–5001.
14. [14] Celato, A., Mitola, C., Tolve, M., Giannini, M.T., De Leo, S., Carducci, C., et al. A new case of malonic aciduria with a presymptomatic diagnosis and an early treatment. Brain Dev 35 (2013), 675–680.
15. [15] Mari, F., Azimonti, S., Bertani, I., Bolognese, F., Colombo, E., Caselli, R., et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 14 (2005), 1935–1946.
16. [16] Ahmed, I., Buchert, R., Zhou, M., Jiao, X., Mittal, K., Sheikh, T.I., et al. Mutations in DCPS and EDC3 in autosomal recessive intellectual disability indicate a crucial role for mRNA decapping in neurodevelopment. Hum Mol Genet 24 (2015), 3172–3180.
17. [17] Kraft, M., Cirstea, I.C., Voss, A.K., Thomas, T., Goehring, I., Sheikh, B.N., et al. Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. J Clin Invest 121 (2011), 3479–3491.
18. [18] Ahmed, M.Y., Chioza, B.A., Rajab, A., Schmitz-Abe, K., Al-Khayat, A., Al-Turki, S., et al. Loss of PCLO function underlies pontocerebellar hypoplasia type III. Neurology 84 (2015), 1745–1750.
19. [19] Beltrán-Valero de Bernabé, D., Currier, S., Steinbrecher, A., Celli, J., van Beusekom, E., van der Zwaag, B., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71 (2002), 1033–1043.
20. [20] Devisme, L., Bouchet, C., Gonzalès, M., Alanio, E., Bazin, A., Bessières, B., et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain 135 (2012), 469–482.
21. [21] Wang, Q., Moore, M.J., Adelmant, G., Marto, J.A., Silver, P.A., PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes Dev 27 (2013), 615–626.
22. [22] Qi, Y., Hoshino, M., Wada, Y.-I., Marubuchi, S., Yoshimura, N., Kanazawa, I., et al. PQBP-1 is expressed predominantly in the central nervous system during development. Eur J Neurosci 22 (2005), 1277–1286.
23. [23] Martínez-Garay, I., Tomás, M., Oltra, S., Ramser, J., Moltó, M.D., Prieto, F., et al. A two base pair deletion in the PQBP1 gene is associated with microphthalmia, microcephaly, and mental retardation. Eur J Hum Genet 15 (2007), 29–34.
24. [24] Ito, H., Shiwaku, H., Yoshida, C., Homma, H., Luo, H., Chen, X., et al. In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells. Mol Psychiatry 20 (2015), 459–471.
25. [25] Budde, B.S., Namavar, Y., Barth, P.G., Poll-The, B.T., Nürnberg, G., Becker, C., et al. tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet 40 (2008), 1113–1118.
26. [26] Klomp, L.W., de Koning, T.J., Malingré, H.E., van Beurden, E.A., Brink, M., Opdam, F.L., et al. Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency—a neurometabolic disorder associated with reduced L-serine biosynthesis. Am J Hum Genet 67 (2000), 1389–1399.
27. [27] Yamasaki, M., Yamada, K., Furuya, S., Mitoma, J., Hirabayashi, Y., Watanabe, M., 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain. J Neurosci 21 (2001), 7691–7704.
28. [28] Tsurusaki, Y., Koshimizu, E., Ohashi, H., Phadke, S., Kou, I., Shiina, M., et al. De novo SOX11 mutations cause Coffin-Siris syndrome. Nat Commun, 5, 2014, 4011.
29. [29] Rex, M., Church, R., Tointon, K., Ichihashi, R.M., Mokhtar, S., Uwanogho, D., et al. Granule cell development in the cerebellum is punctuated by changes in Sox gene expression. Mol Brain Res 55 (1998), 28–34.
30. [30] Scheidecker, S., Etard, C., Haren, L., Stoetzel, C., Hull, S., Arno, G., et al. Mutations in TUBGCP4 alter microtubule organization via the γ-tubulin ring complex in autosomal-recessive microcephaly with chorioretinopathy. Am J Hum Genet 96 (2015), 666–674.
31. [31] Pillai-Kastoori, L., Wen, W., Wilson, S.G., Strachan, E., Lo-Castro, A., Fichera, M., et al. Sox11 is required to maintain proper levels of Hedgehog signaling during vertebrate ocular morphogenesis. PLoS Genet, 10, 2014, e1004491.
32. [32] Wurm, A., Sock, E., Fuchshofer, R., Wegner, M., Tamm, E.R., Anterior segment dysgenesis in the eyes of mice deficient for the high-mobility-group transcription factor Sox11. Exp Eye Res 86 (2008), 895–907.
33. [33] de Paula Freitas, B., de Oliveira Dias, J.R., Prazeres, J., Sacramento, G.A., Ko, A.I., Maia, M., et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol, Feb 9 2016.
34. [34] Jampol, L.M., Goldstein, D.A., Zika virus infection and the eye. JAMA Ophthalmol, 2016.
35. [35] Balestra, F.R., Strnad, P., Flückiger, I., Gönczy, P., Discovering regulators of centriole biogenesis through siRNA-based functional genomics in human cells. Dev Cell 25 (2013), 555–571.
36. [36] Kodani, A., Yu, T.W., Johnson, J.R., Jayaraman, D., Johnson, T.L., Al-Gazali, L., et al. Centriolar satellites assemble centrosomal microcephaly proteins to recruit CDK2 and promote centriole duplication. Elife, 4, 2015, e07519.
37. [37] Sir, J.H., Barr, A.R., Nicholas, A.K., Carvalho, O.P., Khurshid, M., Sossick, A., et al. A primary microcephaly protein complex forms a ring around parental centrioles. Nat Genet 43 (2011), 1147–1153.
38. [38] Morris-Rosendahl, D.J., Kaindl, A.M., What next-generation sequencing (NGS) technology has enabled us to learn about primary autosomal recessive microcephaly (MCPH). Mol Cell Probes 29 (2015), 271–281.
39. [39] Cox, J., Jackson, A.P., Bond, J., Woods, C.G., What primary microcephaly can tell us about brain growth. Trends Mol Med 12 (2006), 358–366.
40. [40] Nigg, E.A., Čajánek, L., Arquint, C., The centrosome duplication cycle in health and disease. FEBS Lett 588 (2014), 2366–2372.
41. [41] Gurling, H.M., Critchley, H., Datta, S.R., McQuillin, A., Blaveri, E., Thirumalai, S., et al. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch Gen Psychiatry 63 (2006), 844–854.
42. [42] Jackson, A.P., Eastwood, H., Bell, S.M., Adu, J., Toomes, C., Carr, I.M., et al. Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet 71 (2002), 136–142.
43. [43] Bond, J., Roberts, E., Mochida, G.H., Hampshire, D.J., Scott, S., Askham, J.M., et al. ASPM is a major determinant of cerebral cortical size. Nat Genet 32 (2002), 316–320.
44. [44] Brasil, P., Pereira, J.P. Jr., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro Nogueira, R.M., et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med, 4, Mar 2016.
45. [45] Rice, G., Patrick, T., Parmar, R., Taylor, C.F., Aeby, A., Aicardi, J., et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 81:4 (Oct 2007), 713–725.
46. [46] Lee-Kirsch, M.A., Wolf, C., Günther, C., Aicardi-Goutières syndrome: a model disease for systemic autoimmunity. Clin Exp Immunol 175 (2014), 17–24.
47. [47] Smith, D.W., Mackenzie, J., Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet, 29, Feb 2016.
48. [48] Cao-Lormeau, V.M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet, 29, Feb 2016.
49. [49] Brasil, P., Pereira, J.P. Jr., Raja Gabaglia, C., Damasceno, L., Wakimoto, M., Ribeiro, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. N Engl J Med, Mar 4 2016.
50. [50] Wakerley, B.R., Uncini, A., Yuki, N., GBS Classification Group, Guillain-Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol 10 (2014), 537–544.
51. [51] Yuki, N., Hartung, H.P., Guillain-Barré syndrome. N Engl J Med 366:24 (2012), 2294–2304.
52. [52] Asbury, A.K., Arnason, B.G., Adams, R.D., The inflammatory lesion in idiopathic polyneuritis: its role in pathogenesis. Medicine (Baltimore) 48 (1969), 173–215.
53. [53] McKhann, G.M., Cornblath, D.R., Griffin, J.W., et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33 (1993), 333–342.
54. [54] Wanschitz, J., Ehling, R., Löscher, W.N., Künz, B., Deisenhammer, F., Kuhle, J., et al. Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome. J Neurol 255 (2008), 917–924.
55. [55] Querol, L., Illa, I., Paranodal and other autoantibodies in chronic inflammatory neuropathies. Curr Opin Neurol 28:5 (Oct 2015), 474–479.
56. [56] Stathopoulos, P., Alexopoulos, H., Dalakas, M.C., Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nat Rev Neurol 11:3 (Mar 2015), 143–156.
57. [57] Querol, L., Nogales-Gadea, G., Rojas-Garcia, R., Martinez-Hernandez, E., Diaz-Manera, J., Suárez-Calvet, X., et al. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73:3 (Mar 2013), 370–380.
58. [58] Rosch, R.E., Bamford, A., Hacohen, Y., Wraige, E., Vincent, A., Mewasingh, L., et al. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases. J Peripher Nerv Syst 19 (2014), 246–249.
59. [59] Devaux, J.J., Odaka, M., Yuki, N., Nodal proteins are target antigens in Guillain-Barré syndrome. J Peripher Nerv Syst 17 (2012), 62–71.
60. [60] Yonekura, K, Yokota, S., Tanaka, S., Kubota, H., Fujii, N., Matsumoto, H., et al. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome. J Neuroimmunol 156 (2004), 204–209.
61. [61] Sawai, S., Satoh, M., Mori, M., Misawa, S., Sogawa, K., Kazami, T., et al. Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. Neurology 83 (2014), 113–117.
62. [62] Kanduc, D., The self/nonself issue: a confrontation between proteomes. Self Nonself 1 (2010), 255–258.
63. [63] Kanduc, D., Lucchese, A., Mittelman, A., Non-redundant peptidomes from DAPs: towards “the vaccine”?. Autoimmun Rev 6 (2007), 290–294.
64. [64] Kanduc, D., Peptide cross-reactivity: the original sin of vaccines. Front Biosci 4 (2012), 1393–1401.